Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-23-002238
Filing Date
2023-11-20
Accepted
2023-11-20 16:29:50
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q axim_10q.htm   iXBRL 10-Q 1355153
2 CERTIFICATION axim_ex311.htm EX-31.1 15447
3 CERTIFICATION axim_ex312.htm EX-31.2 15457
4 CERTIFICATION axim_ex321.htm EX-32.1 3865
5 CERTIFICATION axim_ex322.htm EX-32.2 4354
11 axim_10qimg2.jpg GRAPHIC 4918
  Complete submission text file 0001096906-23-002238.txt   6741923

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axim-20230930.xsd EX-101.SCH 79552
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE axim-20230930_lab.xml EX-101.LAB 415718
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axim-20230930_cal.xml EX-101.CAL 59287
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axim-20230930_pre.xml EX-101.PRE 361325
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axim-20230930_def.xml EX-101.DEF 245384
70 EXTRACTED XBRL INSTANCE DOCUMENT axim_10q_htm.xml XML 908451
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 231423150
SIC: 2834 Pharmaceutical Preparations